This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses of BI 690517

Provided treatments

  • Drug: BI 690517

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02891148. The sponsor of the trial is Boehringer Ingelheim and it is looking for 50 volunteers for the current phase.
Official trial title:
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 690517 in Healthy Male Subjects